Cargando…
Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454228/ https://www.ncbi.nlm.nih.gov/pubmed/37629100 http://dx.doi.org/10.3390/ijms241612919 |
_version_ | 1785096139013357568 |
---|---|
author | Oshitari, Toshiyuki |
author_facet | Oshitari, Toshiyuki |
author_sort | Oshitari, Toshiyuki |
collection | PubMed |
description | Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of neurovascular impairment in DR. Thus, neurovascular cell protection is a potential therapy for preventing the progression of DR. Growing evidence indicates that a variety of cell death pathways, such as apoptosis, necroptosis, ferroptosis, and pyroptosis, are associated with neurovascular cell death in DR. These forms of regulated cell death may serve as therapeutic targets for ameliorating the pathogenesis of DR. This review focuses on these cell death mechanisms and describes potential therapies for the treatment of DR that protect against neurovascular cell death. |
format | Online Article Text |
id | pubmed-10454228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104542282023-08-26 Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy Oshitari, Toshiyuki Int J Mol Sci Review Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of neurovascular impairment in DR. Thus, neurovascular cell protection is a potential therapy for preventing the progression of DR. Growing evidence indicates that a variety of cell death pathways, such as apoptosis, necroptosis, ferroptosis, and pyroptosis, are associated with neurovascular cell death in DR. These forms of regulated cell death may serve as therapeutic targets for ameliorating the pathogenesis of DR. This review focuses on these cell death mechanisms and describes potential therapies for the treatment of DR that protect against neurovascular cell death. MDPI 2023-08-18 /pmc/articles/PMC10454228/ /pubmed/37629100 http://dx.doi.org/10.3390/ijms241612919 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Oshitari, Toshiyuki Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy |
title | Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy |
title_full | Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy |
title_fullStr | Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy |
title_full_unstemmed | Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy |
title_short | Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy |
title_sort | neurovascular cell death and therapeutic strategies for diabetic retinopathy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454228/ https://www.ncbi.nlm.nih.gov/pubmed/37629100 http://dx.doi.org/10.3390/ijms241612919 |
work_keys_str_mv | AT oshitaritoshiyuki neurovascularcelldeathandtherapeuticstrategiesfordiabeticretinopathy |